Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 465

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1B
Chunk 465
---
—  
    $—  
    $843,422 

    Chief Executive and Chief Financial Officer 
     2023  
    $107,500  
    $—  
    $199,510  
    $—  
    $—  
    $307,010 

    Eric Lang(1) 
     2024  
    $446,154  
    $—  
    $230,318  
    $—  
    $—  
    $676,472 

    Chief Medical Officer 
     2023  
    $166,767  
    $—  
    $120,735  
    $—  
    $—  
    $287,502 

    Christian Kopfli 
     2024  
    $—  
    $—  
    $—  
    $—  
    $—  
    $— 

    Former Chief Executive Officer, Former Chief Strategy Officer, and Former Vice Chairman (2) 
     2023  
    $11,280(3)  
    $—  
    $149,633  
    $—  
    $—  
    $160,913 

    (1) 
    Represents the portion
    of Dr. Lang’s salary attributable to his services to the Company during the year ended December 31, 2023. Dr. Lang was
    appointed Chief Medical Officer of the Company, effective May 15, 2023.

    (2) 
    Mr. Kopfli stepped
    down as Chief Financial Officer with the hiring of Mr. Knuettel, effective June 10, 2022. In addition, in July 2023, Mr. Knuettel
    assumed the role of Interim Chief Executive Officer and stepped down as Chief Strategy Officer, and Mr. Kopfli was appointed
    Vice Chairman and Chief Strategy Officer. On December 1, 2023, the Company terminated Mr. Kopfli as Vice Chairman and Chief
    Strategy Officer.

    (3) 
    Represents the portion
    of Mr. Kopfli’s salary attributable to his services to the Company during the years ended December 31, 2023.

88 

Employment
Agreements and Arrangements

Christian
Kopfli 

We
were a party to an amended and restated employment agreement